Building on our group's previous studies, gracillin has been demonstrated to induce G1-phase cell cycle arrest in A549 lung cancer cells and promote apoptosis by regulating Bcl-2 family protein 28, as well as activate autophagy by inhibiting the mTOR signaling pathway 34. Here, MTOR is linked to lung cancer.